« Back
Home /
Secukinumab

Secukinumab

Item no.	TMO-T9930-5mg
Manufacturer	TargetMol
CASRN	1229022-83-6
Amount	5 mg
Quantity options	100mg 10 mg 1 mg 25 mg 50 mg 5 mg
Category	Oncology By Cell Type Hematology Leukemia Reagents & Chemicals Molecules By Organ Bladder Cancer
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	875356-43-7
Shipping condition	Cool pack
Available
Manufacturer - Targets	IL Receptor
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	151 kDa
Description	Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
Pathways	Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T9930-5mg-datasheet.pdf

TMO-T9930-5mg-safety-datasheet.pdf